These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 25014324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 3. Primary central nervous system ALK-negative anaplastic large cell lymphoma: a case report and literature review.
    Yuan C, Duan H, Wang Y, Zhang J, Ou J, Wang W, Zhang M.
    Ann Palliat Med; 2022 Apr 18; 11(4):1554-1560. PubMed ID: 34263607
    [Abstract] [Full Text] [Related]

  • 4. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
    Wang CX, Wang H, Li J, Ma HH, Yu B, Shi SS, Zhou XJ, Shi QL.
    Int J Clin Exp Pathol; 2014 Apr 18; 7(3):1182-7. PubMed ID: 24696735
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
    Pulitzer M, Ogunrinade O, Lin O, Steinherz P.
    J Cutan Pathol; 2015 Mar 18; 42(3):182-187. PubMed ID: 25404214
    [Abstract] [Full Text] [Related]

  • 8. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M.
    Lancet Oncol; 2010 Nov 18; 11(11):1036-47. PubMed ID: 20970380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants.
    Ponzoni M, Terreni MR, Ciceri F, Ferreri AJ, Gerevini S, Anzalone N, Valle M, Pizzolito S, Arrigoni G.
    Ann Oncol; 2002 Nov 18; 13(11):1827-32. PubMed ID: 12419758
    [Abstract] [Full Text] [Related]

  • 11. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ, Reni M, Dell'Oro S, Ciceri F, Bernardi M, Camba L, Ponzoni M, Terreni MR, Tomirotti M, Spina M, Villa E.
    Oncology; 2001 Nov 18; 60(2):134-40. PubMed ID: 11244328
    [Abstract] [Full Text] [Related]

  • 12. Primary central nervous system ALK positive anaplastic large cell lymphoma with predominantly leptomeningeal involvement in an adult.
    Park JS, Park H, Park S, Kim SJ, Seol HJ, Ko YH.
    Yonsei Med J; 2013 May 01; 54(3):791-6. PubMed ID: 23549832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.
    Kim MK, Cho CH, Sung WJ, Ryoo HM, Lee HJ, Youn SW, Park KK.
    Int J Clin Exp Pathol; 2013 May 01; 6(8):1643-51. PubMed ID: 23923083
    [Abstract] [Full Text] [Related]

  • 15. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas.
    Hiraga S, Arita N, Ohnishi T, Kohmura E, Yamamoto K, Oku Y, Taki T, Sato M, Aozasa K, Yoshimine T.
    J Neurosurg; 1999 Aug 01; 91(2):221-30. PubMed ID: 10433310
    [Abstract] [Full Text] [Related]

  • 16. [ALK-negative anaplastic large cell lymphoma with loss of CD30 expression during treatment with brentuximab vedotin].
    Arai H, Furuichi S, Nakamura Y, Nakamura Y, Ichikawa M, Mitani K.
    Rinsho Ketsueki; 2016 May 01; 57(5):634-7. PubMed ID: 27263791
    [Abstract] [Full Text] [Related]

  • 17. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE, Leitenberger JJ, Solomon A, Blauvelt A, Hopkins S.
    Dermatol Online J; 2012 May 15; 18(5):5. PubMed ID: 22630575
    [Abstract] [Full Text] [Related]

  • 18. Primary leptomeningeal ALK+ lymphoma in a 13-year-old child.
    Merlin E, Chabrier S, Verkarre V, Cramer E, Delabesse E, Stéphan JL.
    J Pediatr Hematol Oncol; 2008 Dec 15; 30(12):963-7. PubMed ID: 19131793
    [Abstract] [Full Text] [Related]

  • 19. Primary central nervous system ALK-positive anaplastic large cell lymphoma in an adult: A rare case report.
    Dong X, Li J, Huo N, Wang Y, Wu Z, Lin X, Zhao H.
    Medicine (Baltimore); 2016 Dec 15; 95(49):e5534. PubMed ID: 27930548
    [Abstract] [Full Text] [Related]

  • 20. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K, Shet T, Sridhar E, Dhende S, Sengar M, Arora B, Laskar S, Gujral S, Menon H, Banavali S.
    Indian J Pathol Microbiol; 2017 Dec 15; 60(4):533-540. PubMed ID: 29323068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.